Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study

Detalhes bibliográficos
Autor(a) principal: Rezende, Tatiana M. N.
Data de Publicação: 2017
Outros Autores: Maia-de-Oliveira, João Paulo, Kandratavicius, Ludmyla, Machado-de-Sousa, João Paulo, Abrão, João, Prado, Daniel Almeida, Bressan, Rodrigo A., Lacerda, Acioly L. T., Zuardi, Antonio W., Baker, Glen B., Dursun, Serdar M., Hallak, Jaime E. C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Archives of Clinical Psychiatry
Texto Completo: https://www.revistas.usp.br/acp/article/view/144875
Resumo: Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.
id USP-5_c4663c9775aa489c1eef1025f237363d
oai_identifier_str oai:revistas.usp.br:article/144875
network_acronym_str USP-5
network_name_str Archives of Clinical Psychiatry
repository_id_str
spelling Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind studyNitric oxidesodium nitroprussideketamineschizophreniapsychosis Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria2017-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/acp/article/view/14487510.1590/0101-60830000000141Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 149-153Archives of Clinical Psychiatry (São Paulo); Vol. 44 No. 6 (2017); 149-153Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 149-1531806-938X0101-6083reponame:Archives of Clinical Psychiatryinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/acp/article/view/144875/139102Copyright (c) 2018 Archives of Clinical Psychiatryinfo:eu-repo/semantics/openAccessRezende, Tatiana M. N.Maia-de-Oliveira, João PauloKandratavicius, LudmylaMachado-de-Sousa, João PauloAbrão, JoãoPrado, Daniel AlmeidaBressan, Rodrigo A.Lacerda, Acioly L. T.Zuardi, Antonio W.Baker, Glen B.Dursun, Serdar M.Hallak, Jaime E. C.2018-03-29T16:27:19Zoai:revistas.usp.br:article/144875Revistahttp://www.hcnet.usp.br/ipq/revista/index.htmlPUBhttps://old.scielo.br/oai/scielo-oai.php||archives@usp.br1806-938X0101-6083opendoar:2018-03-29T16:27:19Archives of Clinical Psychiatry - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
title Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
spellingShingle Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
Rezende, Tatiana M. N.
Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
title_short Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
title_full Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
title_fullStr Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
title_full_unstemmed Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
title_sort Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
author Rezende, Tatiana M. N.
author_facet Rezende, Tatiana M. N.
Maia-de-Oliveira, João Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, João Paulo
Abrão, João
Prado, Daniel Almeida
Bressan, Rodrigo A.
Lacerda, Acioly L. T.
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
author_role author
author2 Maia-de-Oliveira, João Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, João Paulo
Abrão, João
Prado, Daniel Almeida
Bressan, Rodrigo A.
Lacerda, Acioly L. T.
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rezende, Tatiana M. N.
Maia-de-Oliveira, João Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, João Paulo
Abrão, João
Prado, Daniel Almeida
Bressan, Rodrigo A.
Lacerda, Acioly L. T.
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
dc.subject.por.fl_str_mv Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
topic Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
description Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.
publishDate 2017
dc.date.none.fl_str_mv 2017-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/acp/article/view/144875
10.1590/0101-60830000000141
url https://www.revistas.usp.br/acp/article/view/144875
identifier_str_mv 10.1590/0101-60830000000141
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/acp/article/view/144875/139102
dc.rights.driver.fl_str_mv Copyright (c) 2018 Archives of Clinical Psychiatry
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Archives of Clinical Psychiatry
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria
dc.source.none.fl_str_mv Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 149-153
Archives of Clinical Psychiatry (São Paulo); Vol. 44 No. 6 (2017); 149-153
Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 149-153
1806-938X
0101-6083
reponame:Archives of Clinical Psychiatry
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Archives of Clinical Psychiatry
collection Archives of Clinical Psychiatry
repository.name.fl_str_mv Archives of Clinical Psychiatry - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||archives@usp.br
_version_ 1824323913432170496